Dystrophic epidermolysis bullosa (DEB) is one of the main subtypes of epidermolysis bullosa, a group of genetic skin ...

The presentation highlighted the potential of human dermal fibroblast (HDF) spheroids in reducing psoriasis severity based on preclinical data, suggesting a scalable cell-based therapy with long ...

A team of researchers from Inserm, the University of Bordeaux, and LVMH Research investigated how hyperglycemia alters human dermis, particularly the cells involved in wound healing, called ...

The poster presentation entitled "Immunomodulatory Potential of Human Dermal Fibroblast Spheroids in Psoriasis Therapy" was presented as a part of a poster session on Friday May 9, 2025. The poster ...

in BCG-unresponsive NMIBC CIS with or without papillary disease Probability of duration of complete response of at least 45 months in the FDA label population (N=77) is 51%, with median duration ...

Keratinocytes – cells in the outermost skin layer – responded rapidly but then began to shut down their response, while fibroblasts – found in the deeper dermis – activated more slowly. This led to ...